Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02925923
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Registry
-
NCT02925923
-
- Other papers using this trial's data
- Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02925923. Randomized; no masking; primary purpose treatment. Start 2016-11-01 (actual); primary completion 2018-01-30 (actual). Results posted on 2020-05-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
- Condition
- Acute Coronary Syndrome
- Condition
- Angina, Unstable
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Eptifibatide
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- University of Alabama at Birmingham
Record details
- Record id
cardio:ct-nct02925923- Content hash
a1bab28b5c7927352b0b1ac042a1900ea4e825767e94382a7ce8a05f6507230a